Fig. 9: Immunofluorescence assay of brains using glial fibrillary acidic protein (GFAP) for neural expression evaluation at 4 months postoperatively. | NPG Asia Materials

Fig. 9: Immunofluorescence assay of brains using glial fibrillary acidic protein (GFAP) for neural expression evaluation at 4 months postoperatively.

From: Multilayered spraying and gradient dotting of nanodiamond–polycaprolactone guidance channels for restoration of immune homeostasis

Fig. 9

Nanodiamond/polycaprolactone (PCL) nerve bridge (a–f). PCL nerve bridge (g–l). Autograft (m–r). Nuclear staining (a, d, g, j, m, p). GFAP staining (b, e, h, k, n, q). Merged images (c, f, i, l, o, r). Scale bar = 1000 μm (a–c, g–i, m–o). Scale bar = 100 μm (d–f, j–l, p–r). Relative GFAP level (s). *p < 0.05 compared with autograft, #p < 0.05 compared with PCL

Back to article page